Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI South Africa ETF (EZA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

iShares MSCI South Africa ETFTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI South Africa ETF vs Zimmer Biomet Holdings Inc — how do they compare? iShares MSCI South Africa ETF trades at $63.06, while Zimmer Biomet Holdings Inc trades at $92.72 (market cap $17.44B). The key difference: Zimmer Biomet Holdings Inc pays a 1.07% dividend while iShares MSCI South Africa ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals.

EZAZBH
Sector
Broad Market / FactorHealth
52-Week High
$81.60$107.71
52-Week Low
$53.05$79.58
Market Cap
$17.44B
Enterprise Value
$24.49B
Dividend Yield
1.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI South Africa ETF

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $91.03, down 3.24% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent earnings beats in recent quarters, with Q2 2026 results pending. Revenue growth has climbed from $6.9B in 2022 to $8.2B in 2025, though net income margin dipped to 8.56%. Recent corporate developments include a $140M acquisition and expansion in India, supporting long-term growth initiatives.

The outlook remains cautiously optimistic with a consensus price target of $97.67, implying 7% upside. Key opportunities include operational efficiency and market share gains, while risks involve debt levels rising to 32.57% of assets and competitive pressures in medical technology. Earnings on August 5 will be critical for near-term direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares MSCI South Africa ETF

EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.

Read more on EZA

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH